DRUGS/PRESCRIPTION: Requires educational or marketing materials for prescription drugs directed to healthcare providers to include price information (OR SEE FISC NOTE GF EX)

HB 277 requires drug manufacturers and marketers to include specific price information in educational or promotional materials provided to healthcare providers. The bill mandates that these materials disclose the average wholesale cost for a 30-day supply (or adjusted duration for shorter treatments) and whether a biosimilar or generic alternative exists for the same condition. This directly affects pharmaceutical companies and marketing entities targeting doctors. Violations would be enforced under Louisiana’s consumer protection laws, but the bill does not regulate actual drug prices or require discounts.